Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
35.17
+0.28 (0.80%)
May 22, 2026, 4:00 PM EDT - Market closed
Qiagen Revenue
Qiagen had revenue of $492.32M in the quarter ending March 31, 2026, with 1.83% growth. This brings the company's revenue in the last twelve months to $2.10B, up 4.79% year-over-year. In the year 2025, Qiagen had annual revenue of $2.09B with 5.65% growth.
Revenue (ttm)
$2.10B
Revenue Growth
+4.79%
P/S Ratio
3.47
Revenue / Employee
$368,222
Employees
5,700
Market Cap
7.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.09B | 111.79M | 5.65% |
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ICON Public Limited Company | 8.10B |
| Charles River Laboratories International | 4.03B |
| Revvity | 2.90B |
| Medpace Holdings | 2.68B |
| RadNet | 2.14B |
| Sotera Health Company | 1.19B |
| Guardant Health | 1.08B |
| Veracyte | 541.74M |
QGEN News
- 4 days ago - QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows - Business Wire
- 5 days ago - Qiagen Digital Insights to integrate Nvidia accelerated computing - TheFly
- 5 days ago - QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA - Business Wire
- 7 days ago - Qiagen price target lowered to $36 from $50 at Stifel - TheFly
- 12 days ago - Qiagen Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Qiagen Slides: FY 2026 - Filings
- 13 days ago - QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting - Business Wire
- 17 days ago - Qiagen price target lowered to $40 from $46 at TD Cowen - TheFly